cdmo.directory
← Compare landing

PolyPeptide Group vs TriLink BioTechnologies

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/polypeptide/trilinkbiotech

CategoryPolyPeptide GroupTriLink BioTechnologies
Listed sitecdmocdmo
SummarySpecialized global CDMO for peptide-based active pharmaceutical ingredients, supporting development and manufacturing of proprietary and generic APIs with expertise in peptide synthesis and GMP manufacturing.TriLink manufactures mRNA, oligonucleotides, and modified nucleotides with proprietary CleanCap® capping technology achieving >95% Cap1 efficiency, supported by in-house analytical method development and a 118,000 sq ft GMP-capable facility.
Services
  • Peptide Manufacturing
  • Process Development
  • Quality Control Testing
  • Technology Transfer
  • CMC Regulatory Submission Support
  • CMC Analytical Development
  • API Synthesis & Manufacturing
  • mRNA Manufacturing
  • Oligonucleotide Manufacturing
  • CMC Analytical Development
  • Process Development
  • Quality Control Testing
  • API Synthesis & Manufacturing
Modalities
  • Peptide
  • mRNA
  • Oligonucleotide
Indications
  • Metabolic
Data not yet provided.
Locations
  • Headquarters, Baar, Switzerland
  • Headquarters
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.